Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to -$13.2 million.

  • National Research's Cash from Financing Activities fell 7772352.94% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year increase of 3789.89%. This contributed to the annual value of -$16.8 million for FY2024, which is 5881.79% up from last year.
  • Per National Research's latest filing, its Cash from Financing Activities stood at -$13.2 million for Q3 2025, which was down 7772352.94% from $6.9 million recorded in Q2 2025.
  • National Research's 5-year Cash from Financing Activities high stood at $6.9 million for Q2 2025, and its period low was -$24.0 million during Q3 2023.
  • Its 5-year average for Cash from Financing Activities is -$7.5 million, with a median of -$5.7 million in 2023.
  • Examining YoY changes over the last 5 years, National Research's Cash from Financing Activities showed a top increase of 35351.65% in 2025 and a maximum decrease of 7772352.94% in 2025.
  • National Research's Cash from Financing Activities (Quarter) stood at -$8.5 million in 2021, then fell by 12.54% to -$9.5 million in 2022, then skyrocketed by 46.45% to -$5.1 million in 2023, then soared by 77.25% to -$1.2 million in 2024, then crashed by 1037.58% to -$13.2 million in 2025.
  • Its Cash from Financing Activities stands at -$13.2 million for Q3 2025, versus $6.9 million for Q2 2025 and -$5.4 million for Q1 2025.